Your browser doesn't support javascript.
loading
FANCM regulates repair pathway choice at stalled replication forks.
Panday, Arvind; Willis, Nicholas A; Elango, Rajula; Menghi, Francesca; Duffey, Erin E; Liu, Edison T; Scully, Ralph.
Afiliação
  • Panday A; Department of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA.
  • Willis NA; Department of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA.
  • Elango R; Department of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA.
  • Menghi F; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06030, USA.
  • Duffey EE; Department of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA.
  • Liu ET; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06030, USA.
  • Scully R; Department of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA. Electronic address: rscully@bidmc.harvard.edu.
Mol Cell ; 81(11): 2428-2444.e6, 2021 06 03.
Article em En | MEDLINE | ID: mdl-33882298
ABSTRACT
Repair pathway "choice" at stalled mammalian replication forks is an important determinant of genome stability; however, the underlying mechanisms are poorly understood. FANCM encodes a multi-domain scaffolding and motor protein that interacts with several distinct repair protein complexes at stalled forks. Here, we use defined mutations engineered within endogenous Fancm in mouse embryonic stem cells to study how Fancm regulates stalled fork repair. We find that distinct FANCM repair functions are enacted by molecularly separable scaffolding domains. These findings define FANCM as a key mediator of repair pathway choice at stalled replication forks and reveal its molecular mechanism. Notably, mutations that inactivate FANCM ATPase function disable all its repair functions and "trap" FANCM at stalled forks. We find that Brca1 hypomorphic mutants are synthetic lethal with Fancm null or Fancm ATPase-defective mutants. The ATPase function of FANCM may therefore represent a promising "druggable" target for therapy of BRCA1-linked cancer.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Helicases / Proteína BRCA1 / Reparo do DNA / Replicação do DNA / Células-Tronco Embrionárias Murinas / Mutações Sintéticas Letais Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Helicases / Proteína BRCA1 / Reparo do DNA / Replicação do DNA / Células-Tronco Embrionárias Murinas / Mutações Sintéticas Letais Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article